The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells.
Détails
ID Serval
serval:BIB_665220B72778
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells.
Périodique
Experimental Cell Research
ISSN
0014-4827 (Print)
ISSN-L
0014-4827
Statut éditorial
Publié
Date de publication
2005
Volume
303
Numéro
2
Pages
321-330
Langue
anglais
Notes
Publication types: In Vitro ; Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Résumé
Constitutive activation of the ras oncoprotein plays a critical role in cancer invasion and metastasis. Particularly, ras-related protease expression such as the serine protease urokinase plasminogen activator (u-PA) has been implicated in mediating cancer cell invasion. Previous studies have shown that ras-mediated u-PA expression is regulated through the mitogen- (MAPK) and stress-activated protein kinase (SAPK) signal transduction pathways extracellular signal-regulated kinase (ERK) and c-Jun-activating kinase (JNK). We therefore asked the question, if ras-related cell invasion might additionally require the third MAPK/SAPK signal transduction cascade, p38. Indeed, we found that ras induces invasion based on the activation of certain p38 protein kinase isoforms, in particular, p38alpha. Moreover, ras activation through transient or stable expression of a Ha-rasEJ mutant induced the expression of u-PA. This was found to be a consequence of an increase of u-PA m-RNA, which was paralleled by only a modest activation of the u-PA promoter. In conclusion, we provide evidence for the requirement of a novel ras-p38alpha-u-PA pathway for ras-dependent cellular invasion.
Mots-clé
Animals, Base Sequence, DNA/genetics, Gene Expression Regulation/drug effects, Genes, ras, Imidazoles/pharmacology, Isoenzymes/genetics, Isoenzymes/physiology, MAP Kinase Signaling System, Mice, NIH 3T3 Cells, Neoplasm Invasiveness/genetics, Neoplasm Invasiveness/physiopathology, Promoter Regions, Genetic/drug effects, Pyridines/pharmacology, Transfection, Urokinase-Type Plasminogen Activator/genetics, p38 Mitogen-Activated Protein Kinases/genetics, p38 Mitogen-Activated Protein Kinases/physiology
Pubmed
Web of science
Création de la notice
21/01/2013 14:21
Dernière modification de la notice
20/08/2019 14:22